Rapidly Progressive Lung Sarcomatoid Carcinoma Managed with Doxorubicin Plus Ifosfamide and Pemetrexed

por Paredes Mogica, Jan Alberto, Reyes Sanchez, Eduardo, Zaragoza Morales, Daniela Arantza, Pierre-Louis Guillen, Nathalie, Magallanes Maciel, Manuel Ernesto
Publicado 2021

Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia

por Chiriches, Claudia, Khan, Dilawar, Wieske, Maria, Guillen, Nathalie, Rokicki, Michal, Guy, Carol, Wilson, Marieangela, Heesom, Kate J., Ottmann, Oliver Gerhard, Ruthardt, Martin
Publicado 2022

STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML

por Oancea, Claudia, Rüster, Brigitte, Brill, Boris, Roos, Jessica, Heinssmann, Maria, Bug, Gesine, Mian, Afsar Ali, Guillen, Nathalie Andrea, Kornblau, Steven M., Henschler, Reinhard, Ruthardt, Martin
Publicado 2014

Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases

por Wannick, Melanie, Bezdek, Siegfried, Guillen, Nathalie, Thieme, Markus, Meshrkey, Fibi, Mousavi, Sadegh, Seeling, Michaela, Nimmerjahn, Falk, Mócsai, Attila, Zillikens, Detlef, Sezin, Tanya, Sadik, Christian D.
Publicado 2018